All News

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

Fam-trastuzumab deruxtecan-nxki has received 4 breakthrough therapy designations, including the latest approval.

Currently, the drug will be studied in the SKYBRIDGE (NCT05652686) trial, a first-in-human, phase 1/2, open-label, dose-escalation and expansion study.

The biosimilar space continues to grow, with key focuses around retina and oncology, but adoption remains slow in the United States.

The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.

Noticing indicators of IVIG non-responsiveness can lead to better outcomes among patients with Kawasaki disease as treatment is adjusted.

Glucagon-like peptide-1 receptor agonists and sodium-glucose contransporter-2 inhibitors have been added as first-line therapy recommendation for type 2 diabetes, the first since metformin

Pharmacists should educate patients about proper medication storage and offer naloxone to optimize safety.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.

Craig Beavers discusses significance of the 2024 update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure.

CAR T-cell therapy in multiple myeloma faces challenges from the immunosuppressive cells in the tumor microenvironment.

Nurx reproductive access survey reveals 28% of women do not believe their right to contraception is protected.

The updates are based on nationwide reports of extreme pain during IUD insertion.

AI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.

Investigators analyzed a series of disease-modifying therapies in a multi-decade trial.

The hemostatic gel is plant-based and designed to stop and control bleeding within seconds after applied to wound at the point of care.

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.

Durvalumab is a human monoclonal antibody that targets and binds to PD-L1 to interrupt tumor immune-evasion tactics.

Setting realistic goals can improve patients’ medication adherence and self-efficacy.

A federal and state policy expert discusses the announcement from the Centers for Medicare & Medicaid Services on the agreement to lower prices for 10 selected drugs due to the Inflation Reduction Act.

The current outbreak has infected more than 14,000 people and spread to 13 different African countries.

Olivia Kinney, a national pharmacy practice manager at Kroger, discusses strategies for pharmacists to effectively address vaccine hesitancy by building trust with patients.

RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.